ArticleFrontiers in medicine2024

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.

Renata Talar-Wojnarowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.